Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WeRide Inc. Board/Management Information 2002

May 31, 2002

49472_rns_2002-05-31_1fca26d0-1b88-4b9b-ab2e-cdea60c9b104.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED 遠東生物制藥科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(the “Company”)

CHANGES OF EXECUTIVE DIRECTORS

This is to announce that with effect from 1 June 2002:—

  • (1) Mr CHEN Wei has been appointed as an executive director of the Company; and

  • (2) Mr LUK Wai Hong has resigned as an executive director of the Company.

The Board of Directors takes this opportunity to acknowledge the contribution of Mr LUK Wai Hong to the Company with the deepest gratitude.

On behalf of the Board CAI Chong Zhen Chairman

Hong Kong, 1 June 2002

Please also refer to the published version of this announcement in the Hong Kong Standard.

— 1 —

FAR EAST PHARMACEUTICAL – CHANGES OF EXECUTIVE DIRECTORS 1ST JUNE, 2002